Novato, CA, June 4, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer, will be presenting at the Goldman Sachs 35th Annual Global Healthcare Conference on June 11, 2014 at 1:20pm PT at Terranea in Rancho Palos Verdes, California.
Help employers find you! Check out all the jobs and post your resume.
